David Liu launches Beam Therapeutics to treat genetic diseases with CRISPR base editing
Wednesday, July 25, 2018 - 14:57
in Biology & Nature
Joined by CRISPR luminaries Feng Zhang and J. Keith Joung, the Harvard chemist raises up to $87 million in funding